AmInvest Research Reports

Hibiscus Petroleum - Legal suit for RM37mil

AmInvest
Publish date: Mon, 06 Mar 2023, 09:18 AM
AmInvest
0 8,766
An official blog in I3investor to publish research reports provided by AmInvest research team.

All materials published here are prepared by AmInvest. For latest offers on AmInvest trading products and news, please refer to: https://www.aminvest.com/eng/Pages/home.aspx

Tel: +603 2036 1800 / +603 2032 2888
Fax: +603 2031 5210
Email: enquiries@aminvest.com

Office Hours
Monday to Thursday: 8:45am – 5:45pm
Friday: 8:45am – 5:00pm
(GMT +08:00 Malaysia)

Investment Highlights

  • We maintain BUY on Hibiscus Petroleum (Hibiscus) with an unchanged sum-of-parts-based fair value of RM1.40/share, which also reflects a premium of 3% for an ESG rating of 4 stars.
  • It implies an enterprise value (EV)/proven and probable reserves (2P) valuation of US$9.17/barrel, at a discount of 19% to EnQuest's US$11.37/barrel and 36% to the regional average of US$14.28/barrel (Exhibit 2).
  • Hibiscus announced that its wholly-owned Hibiscus Oil & Gas Malaysia (formerly known as Repsol Oil & Gas Malaysia) has received a notice of arbitration from a Sarawak-based oil and gas services provider, Oceancare Corporation (Oceancare), claiming a total principal amount of RM36.6mil (2% of Hibiscus’ market cap).
  • This is related to a completed contract for the provision of integrated well services for intervention, workover & abandonment works to Hibiscus Oil & Gas Malaysia earlier. We also understand that Oceancare’s claim is based on variations to the contract’s original scope of works, which was denied by Hibiscus Oil & Gas Malaysia.
  • Note that via Hibiscus Oil & Gas Malaysia, the group holds a 22.3% participating interest in PM3 CAA production sharing contracts (PSC), 60% in Kinabalu Oil PSC, and 60% in PM305/314 PSC.
  • We gather that the group has been engaged in discussions with Oceancare since 2021 to resolve the issues without a satisfactory outcome, leading to the legal dispute. Nevertheless, the group believes it is in a good position to defend itself in the coming lawsuit, after taking advice from its legal counsel.
  • Overall, we are negative on this development which may result in a substantive provision for losses. Under the worstcase scenario of Oceancare winning the lawsuit, we estimate the principal claim may erode the group’s FY23F earnings by a significant 6.4%.
  • Pending an analyst briefing later today to further explain the legal dispute, we keep our forecasts unchanged for now.
  • In terms of outlook, we continue to see near-term resiliency in Hibiscus’ earnings given the enlarged producing asset portfolio from the Repsol assets as well as the still-strong oil prices of above US$80/barrel.
  • The group remains on track to achieve the targeted FY23F sales of 7.2mil–7.5mil barrels of oil, condensate and gas (+57%-63% YoY), mainly banking on incremental output from the full-year contribution of Repsol assets and production enhancement strategies.
  • Currently, Hibiscus is trading at an appealing EV/2P reserve of US$4.14/barrel, at a discount of 64% to its closest peer, UK-listed EnQuest, and 71% to the regional average (Exhibit 2).

Source: AmInvest Research - 6 Mar 2023

Related Stocks
Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment